FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Article

(WDC, NHPR, PWRM, O, EVR) Stock Updates by PennyGovernance.com

Posted, by pennygovernance on June 20th, 2011

Western Digital Corp. (NYSE:WDC) the world's leader in external storage solutions, introduced the WD Nomad™ rugged case (photos), a durable case designed to protect My Passport® portable hard drives from drops as high as seven feet, moisture and spills and other mishaps associated with active, on-the-go lifestyles, such as those of outdoor photographers, adventurers and other road warriors.

WD, one of the storage industry's pioneers and long-time leaders, provides products and services for people and organizations that collect, manage and use digital information. The company designs and produces reliable, high-performance hard drives and solid state drives that keep users' data accessible and secure from loss. Its advanced technologies are configured into applications for client and enterprise computing, embedded systems and consumer electronics, as well as its own consumer storage and home entertainment products.

*******************************

National Health Partners, Inc. (NHPR)

National Health Partners, Inc. is headquartered in Horsham, Pennsylvania. National Health Partners, Inc. Currently offer five standard CARExpress membership programs that provide benefits that range from prescription drug and vision care to comprehensive physician, hospital, vision, dental and other care.

The advantage of health insurance program is very unique. You need not spend a penny from your pocket and the whole cost of treatment is borne by the insurance company. It is a great relief for the members of your family as well because they need not worry about your treatment. A health insurance program is a very useful investment because it helps you at the time when you need the money most. If you do not have the health insurance program for yourself, then you will be in deep trouble when a situation like occurs in front of you and leaves you in want of a huge sum of money.

National Health Partners, Inc. is a national healthcare savings organization that provides discount healthcare membership programs to uninsured and underinsured people through a national healthcare savings network called "CARExpress." CARExpress is one of the largest networks of hospitals, doctors, dentists, pharmacists and other healthcare providers in the country and is comprised of over 1,000,000 medical professionals that belong to such PPOs as CareMark and Aetna. The company's primary target customer group is the 47 million Americans who have no health insurance of any kind. The company's secondary target customer group includes the millions of Americans who lack complete health insurance coverage.

National Health Partners, Inc., a leading provider of discount healthcare membership programs, announced the recent signing of two new significant marketing agreements. These two clients provide very different opportunities and continue to expand the reach of CARExpress into new marketplaces.

By launching their own unique internet marketing program, the first group should be able to provide a widespread push into the on-line market to produce an excellent volume of new CARExpress sales into the pipeline. In addition, the second group offers a reach into the wholesale marketplace where CARExpress will be wrapped into other programs to enhance the value of the overall package to the consumer. We would consider this non-traditional business and a great opportunity to expand our reach as well as recognition of the CARExpress program nationwide.The company plans to announce the rollout of these new marketing campaigns as well as several others over the next few weeks.

For more information about the National Health Partners, Inc. please visit the website: www.nationalhealthpartners.com.

******************************

Power3 Medical Products, Inc (PWRM)

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).

Amyotrophic lateral sclerosis (ALS) - commonly known as Lou Gehrig's disease - is a neuromuscular disorder. It's caused when the motor neurons that send electric "messages" from the brain to the spinal cord or from the spinal cord to the muscles are slowly being destroyed. These neurons are responsible for muscle movement in the body.

When the messages don't get through from the spinal cord, the muscles eventually lose strength and waste away. This process is called atrophy or amyotrophy. When signals from the brain to the spinal cord are blocked, the muscles become stiff and slow. This is called spasticity.

The NuroPro Blood Test is Power3 Medical's diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer's disease, ALS (Lou Gehrig's disease), and Parkinson's disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.

The NuroPro Test is currently in the development stages. The company has completed proof-of-concept and clinical validation studies, with results exceeding expectations. Currently, Power3 Medical has commenced a three hundred patient clinical validation study of its NuroPro diagnostic test for Alzheimer's disease and Parkinson's disease.

Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials.

These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

Power3 Medical Products, Inc please visits their website: http://www.power3medical.com.

********************************

Realty Income Corp. (NYSE:O) announced the pricing of an additional $150 million of its unsecured 5-7?8% senior bonds due 2035. The original offering of $100 million of the 2035 senior unsecured bonds was priced in 2005 and, with this re-opening offering of $150 million, the total principal amount of bonds outstanding due in 2035 will be $250 million. The newly issued unsecured bonds were priced at 94.578% of their principal amount, for an effective yield to maturity of 6.318%. All $250 million of the bonds will have a coupon of 5-7?8%, will trade interchangeably as a single series, and will mature on March 15, 2035. These securities are expected to be rated BBB+ by Fitch Ratings, Baa1 by Moody's Investors Service and BBB by Standard & Poor's Ratings Group. The net proceeds from the offering will be used to fund property acquisitions, and any remaining net proceeds will be used for other general corporate purposes.

Realty Income Corporation engages in the acquisition and ownership of commercial retail real estate properties in the United States. The company leases its retail properties primarily to regional and national retail chain store operators. As of December 31, 2006, it owned 1,955 retail properties located in 48 states, covering approximately 16.7 million square feet of leasable space.

********************************

Evercore Partners Inc. (NYSE:EVR) priced the previously announced underwritten public offering of 4,775,632 shares of its Class A common stock at a public offering price of $32.50 per share. Evercore has agreed to issue and sell 4,665,210 shares of Class A common stock, which will provide approximately $144.8 million in proceeds to Evercore after deducting underwriting discounts and has granted the underwriters a 30-day option to purchase up to 699,781 additional shares of Class A common stock.

Evercore Partners is a leading independent investment banking advisory firm. Evercore's Investment Banking business advises its clients on mergers, acquisitions, divestitures, restructurings, financings, public offerings, private placements and other strategic transactions and also provides institutional investors with high quality research, sales and trading execution that is free of the conflicts created by proprietary activities.

Sign up for free stock alerts at http://www.pennygovernance.com/signup

***************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyGovernance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyGovernance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.(read more @ http://pennygovernance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 3,000,000 shares of (144) restricted common stock from the company and 3,000,000 shares of free trading shares from a third party (PIERRE BESUCHET) for six months of advertisement services for National Health Partners Inc. (NHPR.OB). Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

READ MORE AT: 
Authored by, pennygovernance
Site:
N/A
Log in or register to post Private Message
Tickers:
EVR | O | WDC
Tags:
General Market News, O, WDC, pwrm, EVR, NHPR
Advertise with us

Add new comment

By submitting this form, you accept the Mollom privacy policy.